Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,256,884
-$140,762 QoQ
Shares Held
20,040
-4.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#665
of 3,140 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026World Investment Advisors holds $141,718,806 across 14 Drug Manufacturers - General names. AMGN ranks #6 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
138,212 | $35,101,701 | |
| 2 | LLY |
ELI LILLY & Co
|
25,879 | $31,040,051 | |
| 3 | ABBV |
AbbVie Inc.
|
121,763 | $30,640,441 | |
| 4 | MRK |
Merck & Co., Inc.
|
65,711 | $8,443,863 | |
| 5 | PFE |
Pfizer Inc
|
321,367 | $7,738,517 | |
| 6 | AMGN |
Amgen Inc
This page
|
20,040 | $7,256,884 | |
| 7 | NVS |
Novartis AG
|
44,423 | $6,961,972 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
28,563 | $3,608,649 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,256,884 | 20,040 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,397,646 | 21,025 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $6,866,636 | 20,979 | Shares | Sole | 2026-03-13 | |
| 2025-09-30 | $5,500,924 | 19,493 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $5,328,722 | 19,085 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $5,283,575 | 16,959 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $4,369,890 | 16,766 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $3,571,053 | 11,083 | Shares | Sole | 2024-11-25 | |
| 2024-06-30 | $2,333,064 | 7,467 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $504,952 | 1,776 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $953,922 | 3,312 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $502,043 | 1,868 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $333,474 | 1,502 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $363,108 | 1,502 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $412,607 | 1,571 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $442,911 | 1,965 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $532,827 | 2,190 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $535,389 | 2,214 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $515,181 | 2,290 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $540,343 | 2,541 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $548,681 | 2,251 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $510,558 | 2,052 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $435,928 | 1,896 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $513,403 | 2,020 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $443,888 | 1,882 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||